Perrigo (PRGO) Goodwill & Intangibles (2013 - 2026)
Perrigo (PRGO) posted quarterly Goodwill & Intangibles of $4.0 billion for Q1 2026, down 32.08% year-over-year from $5.8 billion in Q1 2025, and down 10.01% quarter-over-quarter from $4.4 billion in Q4 2025.
Perrigo (PRGO) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Goodwill & Intangibles for 14 consecutive years, with $4.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 32.08% year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (down 32.08% YoY), while the FY2025 annual figure was $4.4 billion, down 23.37% from the prior year.
- Goodwill & Intangibles declined to $4.0 billion in Q1 2026 per PRGO's latest filing, from $4.4 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $6.7 billion in Q3 2022 and bottomed at $3.2 billion in Q2 2023.
- Historically, Goodwill & Intangibles has averaged $5.8 billion across 5 years, with a median of $6.0 billion in 2025.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles slumped 37.02% — and 2024, when it jumped 101.08%.
- Perrigo's Goodwill & Intangibles stood at $6.7 billion in 2022, then retreated by 3.14% to $6.5 billion in 2023, then dropped by 11.77% to $5.7 billion in 2024, then dropped by 23.37% to $4.4 billion in 2025, then declined by 10.01% to $4.0 billion in 2026.
- Business Quant data shows PRGO's Goodwill & Intangibles at $4.0 billion in Q1 2026, $4.4 billion in Q4 2025, and $5.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 3.88 Bn |
| Mar 28, 2026 | 3.96 Bn |
| Dec 31, 2025 | 4.40 Bn |
| Sep 27, 2025 | 5.76 Bn |
| Jun 28, 2025 | 6.04 Bn |
| Mar 29, 2025 | 5.83 Bn |
| Dec 31, 2024 | 5.74 Bn |
| Sep 28, 2024 | 6.08 Bn |
| Jun 29, 2024 | 6.00 Bn |
| Mar 30, 2024 | 6.36 Bn |
| Dec 31, 2023 | 6.51 Bn |
| Sep 30, 2023 | 6.49 Bn |
| Jul 1, 2023 | 6.63 Bn |
| Apr 1, 2023 | 3.16 Bn |
| Dec 31, 2022 | 6.72 Bn |
| Oct 1, 2022 | 6.43 Bn |
| Jul 2, 2022 | 6.74 Bn |
| Apr 2, 2022 | 5.02 Bn |
| Dec 31, 2021 | 5.15 Bn |
| Oct 2, 2021 | 5.26 Bn |